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Abstract
The ignorability assumption and the overlap condition are key assumptions in causal
inference. They are commonly made, but often violated in observational studies. In this
paper, we investigate a local version of the ignorability assumption for continuous treat-
ments, where potential outcomes are independent of the treatment assignment only in a
neighborhood of the current treatment assignment. Similarly, we introduce a local version
of the overlap condition, where the positivity assumption only holds in a neighborhood of
observations. Under these local assumptions and a smoothness condition, we show that the
effect of shifting a continuous treatment variable by a small amount across the whole pop-
ulation (termed average partial effect or incremental causal effect) is still identifiable, and
that the incremental causal effect can be estimated via the average derivative. Moreover, we
prove that in certain regression settings, estimating the incremental effect is easier than es-
timating the average treatment effect in terms of asymptotic variance. In addition, we show
that estimation of incremental causal effects is often more robust than estimating average
treatment effects if the ignorability assumption is slightly violated. For high-dimensional
settings, we develop a simple feature transformation that allows for doubly-robust estima-
tion and doubly-robust inference of incremental causal effects. Finally, we compare the
behaviour of estimators of the incremental treatment effect and average treatment effect in
experiments including data-inspired simulations.
1 Introduction
The estimation of treatment effects has a long history in many disciplines and is of central
interest in many data science (both scientific and business) endeavours. Often, data from a
randomized experiment is not available and one has to resort to observational data. In this
situation, practitioners usually mitigate the problem using regression adjustment, matching,
inverse probability weighting or instrumental variables regression.
The overall goal in causal inference is to estimate the effect of intervening on a treatment T
on an outcome Y . Average treatment effect and conditional average treatment effect are often
the quantities of interest in causal inference, where a treatment variable T is set to the same
level across a certain population. In the Neyman-Rubin model, if Y (t) denotes the potential
outcome of a unit with treatment assignment t (Rubin, 1974; Splawa-Neyman et al., 1990), this
can be expressed as
E[Y (t′)]− E[Y (t)], for some fixed t, t′ ∈ R,
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where the expectation is taken over a superpopulation. However, there also exist other notions
of interventions. For continuous treatment one may want to estimate the effect of shifting a pre-
interventional (potentially random) assignment T by an infinitesimal amount across a certain
population. Mathematically, this can be expressed as
E[Y (T + δ)]− E[Y (T )]
δ
for deterministic δ > 0 close to zero, (1)
where the expectation is taken over a superpopulation of units. This notion of intervention is
much less used in parts of the causal inference community. The effect in equation (1) corre-
sponds to average partial effects in the econometrics literature, which refer to the effect of an
infinitesimal shift in structural equation models (Powell et al., 1989; Cameron and Trivedi, 2005;
Wooldridge, 2005). More precisely, in the literature sometimes “average partial effect” refers to
the causal estimand, sometimes it refers to the functional E[∂tE[Y |X,T ]]. To distinguish the
causal estimand from the functional E[∂tE[Y |X,T ]], following Kennedy (2018), we refer to the
estimand in equation (1) as an incremental treatment effect.
Practitioners have to decide how to specifically formulate a domain question and which
notion of intervention to employ to answer the domain question. Of course, these notions
correspond to different domain questions, and the domain question is one of the most important
factors for the choice of intervention notion. We would argue that issues of identification,
robustness to confounding and difficulty of the estimation task (asymptotic error) should also
play important roles in the choice of intervention notion.
As mentioned previously, treatment effects are often estimated under the assumptions of
weak ignorability and the overlap condition. However, these assumptions can be unrealistic
or hard to justify if the data is observational. We introduce a local ignorability assumption
and a local overlap condition, which are weaker than their more general counterparts. Roughly
speaking, the local ignorability assumption states that potential outcomes are independent of
the current treatment assignment in a neighborhood of observations. It will turn out that
incremental treatment effects are identifiable under these assumptions, while average treatment
effects are not. To the best of our knowledge, tailor-made assumptions to identify incremental
treatment effects for continuous treatments have not been defined previously.
In situations where the practitioner suspects some latent confounding, it would be sensible
to employ a notion which is the least sensitive to confounding, if possible. We will see that
incremental effects are often more robust under worst-case additive confounding than average
treatment effects if the weak ignorability assumption is slightly violated. If the signal-to-noise
ratio is low, then estimation of average treatment effects might be highly variable and thus un-
informative. We will discuss situations in which incremental treatment effects can be estimated
with lower asymptotic error than average treatment effects. This includes situations where the
signal to noise ratio is low. Thus, estimating incremental treatment effects is potentially more
informative than estimating average treatment effects if incremental treatment effects help solve
the domain problem.
Causal inference from observational data is known to be challenging and prone to mistakes
Rosenbaum (2002), with sometimes devastating effects for human lives. Revisiting the con-
ceptual foundations of the field may help us distinguish situations in which some notions of
interventions can be estimated more reliably than others and are thus more informative. In this
work, we investigate advantages and disadvantages of incremental treatment effects compared
to average treatment effects under the local ignorability assumption and overlap condition. We
hope that our work aids practical decisions on choice of intervention notions to answer a specific
domain question.
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1.1 Related work
For discrete treatments, Kennedy (2018) defines incremental propensity score interventions by
multiplying the odds of receiving treatment. The author shows that the overlap assumption
is not necessary for identifying incremental propensity score interventions and develops an
efficiency theory with corresponding nonparametric estimators.
Asymptotic equivalence of several estimators of the average partial effect in parametric
settings has been shown in Stoker (1991). To the best of our knowledge, semiparametric esti-
mation of average derivatives has first been discussed in Powell et al. (1989). More recently,
Chernozhukov et al. (2018) and Hirshberg and Wager (2019) derived semiparametrically efficient
estimators of linear functionals of the conditional expectation function. In Hirshberg and Wager
(2019), this is achieved under Donsker assumptions, while Chernozhukov et al. (2018) employ a
sparsity assumption on either the approximation of the Riesz representer or the approximation
to the regression function.
Hirano and Imbens (2004) generalize the unconfoundedness assumption to continuous treat-
ments. This allows to identify the dose-response function using a generalized propensity score.
Under the assumption of our framework, the dose-response function is generally not identifiable.
When there exists a binary instrumental variable, under non-compliance average treatment
effects are usually not identifiable. In Angrist et al. (1996), the authors show that under a
monotonicity assumption, interventions on the subgroup of compliers, the so-called local average
treatment effect is still identifiable. In fact, estimating the effect of this “weaker” notion of
treatment effect in cases where the average treatment effect is not identifiable is increasingly
popular in certain parts of the causal inference community (Imbens, 2010).
In models based on structure equations, incremental interventions can be seen as a special
case of “parametric” or “imperfect” interventions (Eberhardt and Scheines, 2007; Korb et al.,
2004; Tian and Pearl, 2001; Pearl and Bareinboim, 2014). Korb et al. (2004) argue that naively
estimating (deterministic) causal effects using Bayesian networks can be misleading and discuss
different types of indeterministic interventions. In the context of structure learning, Eberhardt
and Scheines (2007) have shown that causal systems of N variables can be identifiable using one
parametric intervention. Tian and Pearl (2001) do structure learning based on local mechanism
changes, which are a more general notion of intervention than incremental effects.
1.2 Our contribution
We show that the effect of incremental interventions is identifiable under a local ignorabil-
ity assumption and a local overlap condition, which can be seen as relaxed versions of their
more general counterparts. To our best knowledge, this is the first time that one deals with
identifiability issues for incremental treatment effects in the potential outcome framework.
In regression settings, the distribution of the treatment variable given the covariates is Gaus-
sian, using nonlinear basis expansions, we show that incremental subpopulation causal effects
can be estimated efficiently with usually lower asymptotic error than average treatment effects.
Furthermore, we show that the estimation of incremental causal effect in a regression setting
in the population case is usually less sensitive to additive unobserved confounding compared to
the estimation of average treatment effects.
We propose a feature transformation “incremental effect orthogonalization” that facilitates
estimation and inference of high-dimensional incremental causal effects. Our method is based
on a feature transformation in the first step and running a de-sparsified lasso on the transformed
data. The de-sparsifying technique is similar to the ones developed for high-dimensional linear
regression (Zhang and Zhang, 2014; Javanmard and Montanari, 2014; Van de Geer et al., 2014;
Belloni et al., 2014) but due to the randomness in treatment assignment the asymptotic variance
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formula differs from existing approaches for inference in high-dimensional regression models. We
modify a robust version of the desparsifying approach which was introduced in Bu¨hlmann and
van de Geer (2015). Our novel technique has a double-robustness property, in the sense that if
one of two models is well-specified, we obtain asymptotically valid estimation and inference. The
main advantage compared to existing approaches for the estimation of incremental treatment
effects is that after a simple feature transformation, off-the-shelf software for estimation in
high-dimensional linear models can be used.
To substantiate the claims of our theoretical results, we compare the behaviour of estimators
of the incremental treatment effect and average treatment effect on simulated data. We also
cover simulations settings where the assumptions of some of our theoretical results are violated
and discover that the conclusions are fairly robust.
The rest of the paper is organized as follows. In Section 2 we introduce the model class. In
Section 3, we discuss identification of the incremental treatment effect under a local ignorability
and local overlap condition. In Section 4, we discuss models in which estimating incremental
treatment effects is more robust under confounding and can be done with lower asymptotic error
than estimating average treatment effects. Furthermore, we introduce a feature transformation
that facilitates doubly robust estimation and inference in high-dimensional settings. Finally,
in Section 5 we validate our theoretical results on simulated data, including set-ups based on
real-world data.
2 Motivation and setup
We are interested in the causal effect of a continuous treatment variable T on an outcome Y in
the presence of some covariates X ∈ Rd. We use the Neyman-Rubin potential outcome frame-
work (Rubin, 1974; Splawa-Neyman et al., 1990) and assume a super population or distribution
P of (Y (t)t∈R, T,X) from which N independent draws (Yi(Ti), Ti, Xi) are given, where Yi(t) is
the potential outcome of Y under treatment or dose T = t. Without any assumptions or ad-
justment, an observed association between T and Y might simply be due to some confounding
variable that affects both the treatment and the outcome. A commonly made assumption in
such a setting is weak ignorability (Rosenbaum and Rubin, 1983), which states that the treat-
ment assignment is independent of the outcome, conditional on some covariates X. Formally,
this assumption is often written as
{Y (t), t ∈ T } ⊥ T |X, (2)
where Y (t) is defined as the potential outcome of Y under treatment T = t and T is the set
of treatment levels. To avoid issues of measurability, we assume that Y (t) is continuous. In
addition, it is common to assume that the overlap condition holds, which can be written as
p(t|x) > 0 for all t, x, (3)
where p(t|x) is the conditional density of T given X and p(x) is the density of X. If both weak
ignorability and the overlap condition holds, the average treatment effect E[Y (t)]−E[Y (t′)] for
some choice of t, t′ ∈ T can be estimated via regression, matching, inverse probability weighting
or combinations of these methods, see for example Rosenbaum (2002). In particular,
E[Y (t)]− E[Y (t′)] = E[E[Y |X,T = t]]− E[E[Y |X,T = t′]],
where on the right-hand side the outer expectation is taken over the distribution of X.
In the following we will show that incremental causal effects are identifiable in scenarios
where the ignorability assumptions holds locally in subgroups of patients with similar treatments
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but not necessarily across all patients. In addition, we show that the overlap condition can be
weakened as well. Average treatment effects and the dose-response function are generally not
identifiable under these assumptions.
Throughout the paper we assume that the Stable Unit Treatment Value Assumption (Rubin,
1980; Hernan and Robins, 2010) holds, which says that the potential outcomes are well-defined
and that there is no interference between units, i.e. that the potential outcome of one individual
is only a function of the treatment assignment to this individual and not of the others. Formally,
this assumption can be expressed as Yi(T) = Yi(Ti) for T = (T1, . . . , Tn).
2.1 Local ignorability
In practice there are cases where the weak ignorability assumption in equation (2) might be
unrealistic. For example, if T describes the dose of a medication, the patients receiving high
doses of the medication may be a completely different population than the patients receiving low
doses of the medication, even conditional on the covariates X. If X = “severity of symptoms”
and there is a patient that has severe symptoms and receives a a very low dose, this might be
due to the doctor making an exceptional decision due to an exceptional circumstance that is not
encoded in the data set. This exceptional circumstance might also affect the outcome. It could
also be that the patient willingly decides to take only a lower dose than usual. Consequentially,
this patient may make other decisions that affect Y (t) that are not encoded in X. In the
following, we introduce a localized version of the ignorability assumption which allows for some
unobserved heterogeneity.
From the ignorability assumption, by conditioning on T , the following condition follows
immediately. Ignoring measure-theoretic special cases where the condition below is not well-
defined, equation (2) is practically equivalent to the assumption below. The reformulation is
similar to Hernan and Robins (2010, p. 15).
Assumption 1 (Weak ignorability assumption, reformulated). Assume that
Y (t)|{X = x, T = t′} d= Y (t)|{X = x, T = t′′} for all t, t′, t′′.
Thus, one way to think about the ignorability assumption is that, conditionally on X = x,
the distribution of the potential outcomes is the same across patients with different treatment
assignments. In the following, to deal with certain violations of equation (2) as discussed in the
previous chapter, we will define a local version of this assumption.
Assumption 2 (Local ignorability). Assume that for almost all (x, t0) with p(x, t0) > 0
Y (t)|{X = x, T = t′} d= Y (t)|{X = x, T = t′′}, (4)
for all max(|t− t0|, |t′ − t0|, |t′′ − t0|) ≤ δ0, where δ0 > 0 can depend on x and t0.
Roughly speaking, we assume that patients are “comparable” (i.e. have the same potential
outcome in distribution), if they have a treatment assignment that is sufficiently similar. In
other words, we assume that treatment assignments are randomized locally but not necessarily
globally. This can happen, for example, if a doctor has discrete groups of patients that he treats
differently. Then the treatment assignment might be (approximately) random between patients
with similar treatments, but not between patients with very different treatments. An example
is given in Figure 1. Even if the group assignment is not observed (unobserved confounder), the
incremental causal effect can be identifiable, as we will see below. Thus, the local ignorability
assumption allows for some unobserved heterogeneity.
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Figure 1: In this example, assume that the weak ignorability assumption holds for each of the
patient groups A, B, C and D. In general, conditionally on X, the weak ignorability assumption
is thus violated for the total patient population. On the other hand, as the boundaries of the
groups are a null set, the local ignorability assumption holds.
2.2 Local overlap
Now let us turn to weakening the overlap condition. If the overlap condition is not satisfied,
parts of the population are observed with probability zero for some treatment T = t. Estimating
a causal effect for this part of the population amounts to extrapolating from other parts of the
population, which is naturally prone to errors. In practice, the overlap condition is often not
satisfied. In the example discussed above, ethical considerations, among others, might prevent
doctors to give a very low dose to patients with severe symptoms and a very high dose to
patients with minor symptoms. If X = “severity of symptoms”, then by conditioning on a
large value X = x we will have only very few patients with low doses, or no patients at all.
This makes it exceedingly difficult to estimate the effect of giving a low dose to this group of
patients. In finite samples, estimation of the average treatment effects is difficult if there exists
regions where assignment variables t has low density and the other treatment assignment t′
has high density. This issue can be exacerbated if the covariate vector X is high-dimensional
and the data is observational (D’Amour et al., 2017). Roughly speaking, due to the curse of
dimensionality, in high-dimensions there will often be regions where one of the treatments has
low density. A similar problem appears in practice when trying to match subjects on many
covariates. The more covariates we have, the harder it is to find pairs of subjects that are
similar in all covariates.
High-dimensional covariates are potentially also challenging for the estimation of incremental
effects. However, for the estimation of incremental effects, we can relax the overlap condition.
In the following we assume that the density functions p(t, x) and p(t|x) exists.
Assumption 3 (Local overlap). Assume that p(t, x) and p(t|x) are continuous.
Roughly speaking, we assume that if there is a patient with severity X = x that gets
treatment T = t then the probability of another patient with slightly different severity and
treatment is nonzero. An example is given in Figure 2.
2.2.1 Regularity assumption
Here we make an assumption to guarantee that the conditional expectations used in this paper
exist. In practice, these assumptions can be thought of as putting a smoothness condition on
the potential outcomes.
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patients
Figure 2: Let the ellipsoid denote the region of positive density, {(x, t) : p(x, t) > 0}. In this
example, the overlap condition is violated as there are no patients that have strong symptoms
X = x but get a low dose T = t. On the other hand, the local overlap condition holds if the
densities are continuous.
Assumption 4 (Regularity). Assume that the potential outcomes Y (t) are bounded and that
the derivative Y ′(t) := ∂tY (t) is continuous and bounded.
This assumption can be slightly relaxed. Instead of asking for smoothness of the potential
outcomes, we could assume a smoothness condition for the regression surface E[Y |X = x, T = t].
We will work with the regularity condition as defined above for reasons of simplicity.
3 Identification of incremental causal effects
Note that if we only have the local ignorability assumption or the local overlap condition, it is
generally not possible to consistently estimate (or identify) the average treatment effect
E[Y (t)]− E[Y (t′)] for some t, t′ ∈ R.
However, we will now show that the effect of shifting t by a small amount around the current
treatment can still be identifiable. In the following, we assume that Assumption 4 holds, i.e. we
make the assumption that Y (t) is bounded and continuously differentiable in t with bounded
derivative. Together with the local ignorability assumption and the local overlap condition, it
implies that E[Y |X = x, T = t] exists and is differentiable in t for all (x, t) with p(x, t) > 0.
The short proof of the following result can be found in Section 8.2 in the Appendix.
Proposition 1. If Assumption 2 (local ignorability), Assumption 3 (local overlap) and Assump-
tion 4 (regularity) are satisfied, then for almost all (x, t) with p(x, t) > 0,
E[Y ′(t)|X = x, T = t] = ∂tE[Y |X = x, T = t].
Note that Assumption 4, which assumes that Y (t) is bounded and differentiable with
bounded derivative, is made for expositional clarity and can be weakened slightly.
In the following we have to differentiate between the incremental effect for the superpopula-
tion and the incremental effect for the sample. In the latter case, all statements are conditional
on the units that we observe. More information for the difference between population causal
effects and finite sample causal effects can be found in Imbens and Rubin (2015), Section 1.
More specifically, we will investigate estimation and inference for the expected effect of an
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infinitesimal shift intervention for a finite sample (yi, ti, xi), i = 1, . . . , n,
θfs :=
1
n
n∑
i=1
E[Y ′(ti)|X = xi, T = ti], (5)
where the expectation is taken with respect to the potential outcomes Y given X = x and
T = t. We allow for randomness in Y after conditioning on X = x and T = t. This can account
for within-subject variability of treatment effects. For example, for a given subject we allow
the treatment effect to vary across time. In words, θfs corresponds to the expected effect of
an incremental intervention conditionally on (ti, xi)i=1,...,n. We condition on the (ti)i=1,...,n as
we aim to estimate the effect of slightly shifting the current treatment assignments (ti)i=1,...,n.
Note that we do not condition on (yi)i=1,...,n as is sometimes done in the causal inference
literature for binary treatments (Imbens and Rubin, 2015). Conditioning on the yi, in addition
to conditioning on the ti and xi, would result in a deterministic sample and is thus not practical.
For n→∞, under some regularity conditions and a super population model, θfs will converge
to the super population effect,
θsp := E[Y ′(T )]. (6)
Here, the expectation is taken over T , X and Y . In words, θsp corresponds to the expected
effect of an incremental intervention on the superpopulation. We want to emphasize that the
interpretation of these causal effects is different from the most common notion of interventions,
so-called average treatment effects, surgical interventions or do-interventions. The population
incremental causal effect answers the question: “How will the average outcome change if we
change the treatment of all patients by a small amount, i.e. use treatment assignment T ′ = T+δ
across all patients” for some δ close to zero. Note that the quantities of interest are in general
also different from
E[Y ′(t)],
which corresponds to first setting the value of T to t across the whole population and than vary-
ing that intervention by a small amount. In the next section we will discuss general properties
of estimation and inference of the effect in equation (5) and equation (6).
4 Estimating incremental effects in regression settings
In this section we discuss various aspects of estimation and inference for incremental causal
effects for the sample incremental effect θfs and the population incremental effect θsp. In Sec-
tion 4.1 we discuss regression settings for which the error of efficiently estimating the effect
of shift interventions is lower than the error of efficiently estimating average treatment effects.
This is achieved if the conditional distribution p(t|x) is Gaussian. In Section 4.2 we show that
estimation of incremental interventions is usually less sensitive to worst-case confounding than
estimation of average treatment effects. In Section 4.3 we discuss a feature transformation that
facilitates obtaining confidence statements in high-dimensional scenarios. The main advantage
compared to existing approaches (Powell et al., 1989; Hirshberg and Wager, 2019; Chernozhukov
et al., 2018) is that after a simple feature transformation, off-the-shelf software for estimation
and inference in high-dimensional linear models can be used.
4.1 Variance comparison
In this section we will see that in some standard regression settings, the squared error of esti-
mating the sample average treatment effect is often larger than the squared error of estimating
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the sample effect of incremental interventions for regression estimators. We assume that we
observe n i.i.d. observations (xi, ti, yi), i = 1, . . . , n, of distribution P that follow the additive
noise model
Y = f0(T,X) + , (7)
where  is independent of T and X, E[] = 0 and Var() = σ2 > 0. We assume that f0 is
differentiable in t, i.e. we make a smoothness assumption on how the treatment affects the
outcome. As an example, y could be the math score of a student in a test, t the study time
after class and x pre-treatment covariates such as age and gender.  could be the influence
of some other unmeasured factors that are independent of X and T but have an influence
on the math score. In the easiest case, the function f0 is linear in its arguments, but often
there will be interactions between the pre-treatment covariates and study time after class. If
x = “doing at least two hours of sports per week”, then the effect of studying on the outcome
y might be stronger if the student does enough sports.
Under the assumptions of Proposition 1, we have θfs =
1
n
∑n
i=1 ∂tf
0(ti, xi). We can estimate
θfs via a two-stage procedure in non-parametric settings. First, choose differentiable basis
functions b1, . . . , bp. These functions can for example include linear terms, polynomials, radial
basis functions or wavelets. Ideally, the choice of basis functions is guided by domain knowledge.
In cases where domain knowledge is not available, we recommend using linear and quadratic
terms. First, we solve the least-squares problem
βˆ = arg min
β
n∑
i=1
(
yi −
p∑
k=1
bk(ti, xi)βk
)2
.
Secondly, we estimate the derivative via θˆ = 1n
∑
i
∑
k βˆk∂tbk(ti, xi). For some t
′ 6= t, we compare
the performance of this estimator with a naive estimator
τˆ(t, t′) =
1
n
n∑
i=1
fˆ(t, xi)− fˆ(t′, xi)
t− t′ , (8)
where fˆ =
∑
k βˆkbk(ti, xi). Under weak ignorability, this is an estimator of the (normalized)
sample average treatment effect
τfs(t, t
′) :=
1
n
n∑
i=1
E[Y (t)|X = xi, T = t]− E[Y (t′)|X = xi, T = t′]
t− t′ .
We normalize the average treatment effect such that if the treatment effect is linear, τfs and
θfs agree. Define B as the linear span of b1, . . . , bp. Write Xj;i = bj(ti, xi). Here and in the
following, to be able to use partial integration we tacitly assume that bk(t, x)p(t|x) → 0 and
∂tbk(t, x)p(t|x)→ 0 for fixed x and |t| → ∞.
Theorem 1 (Asymptotic variance comparison). Assume that the data (yi, ti, xi), i = 1, . . . , n
are i.i.d. and follow the model in equation (7). Furthermore, assume that ∂t log p(t, x) ∈ B and
f0 ∈ B. Let b1(t, x), . . . , bp(t, x) be differentiable and let (bk(T,X))k=1,...,p and (∂tbk(T,X))k=1,...,p
have finite second moments. If the conditional distribution p(t|x) suffices ∂2t log p(t|x) ≡ 0 for
all t, x, then for all t, t′ ∈ R,
lim sup
n→∞
E[(θˆ − θfs)2|Dfeat]
E[(τˆ − τfs)2|Dfeat] ≤ 1,
where Dfeat = {(xi, ti), i = 1, . . . , n}.
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The theorem implies that the simple plug-in estimator θˆ has asymptotically lower error or the
same error as τˆ if B is large enough and p(t|x) is Gaussian. The difference in asymptotic variance
can be drastic, as we will see in the simulation section. Hence, the concept of incremental
interventions might be helpful in situations where the signal-to-noise ratio is too low for drawing
any conclusions from τˆ .
The estimators above are both efficient for estimating their respective target quantities
within the class of unbiased and linear estimators (Van der Vaart, 2000). In this sense, the
result above shows that in low-dimensional scenarios, estimating sample incremental causal
effects θfs is easier in terms of optimal asymptotic variance. Thus, if the domain problem is
adequately addressed in the incremental causal effect formulation, estimating incremental causal
effects might be more informative than estimating average treatment effects.
We will discuss scenarios in which estimation of average treatment effects results in lower
asymptotic variance than estimating incremental treatment effects in Section 5. While the
theoretical result above makes relatively strong assumptions on the distribution of T , in practice
the effect seems fairly robust.
4.2 Sensitivity to additive confounding
In this section we discuss how estimation of average treatment effects and incremental causal
effects behaves in the super-population case if the ignorability assumption is slightly violated.
Analysing the sensitivity of causal effects with respect to violations of assumptions plays a
central role in observational studies, see for example Cornfield et al. (1959); Rosenbaum and
Rubin (1983); Rosenbaum (2002). Roughly speaking, we will see that estimation of incremental
treatment effects is relatively little affected by confounding if the variation of the treatment
variable T is high compared to the variation of confounding H. In addition, we will show that
average treatment effects are usually more sensitive to worst-case additive confounding than
incremental causal effects in this setting. Before we proceed, we need some additional notation.
Let Punconf denote the distribution of (Y, T,X) and assume that the weak ignorability and
overlap condition holds under Punconf. Then, the (relative) average treatment effect is identifiable
via τsp = τ(Punconf), where
τ(P) =
E[E[Y |X = X,T = t]]− E[E[Y |X = X,T = t′]]
t− t′ ,
for some t 6= t′. Analogously, the incremental effect can be identified via θsp = θ(Punconf), where
θ(P) = E[−∂t log p · Y ] = E[∂tE[Y |X,T ]].
In the following we investigate how the functionals τ(·) and θ(·) behave under additive con-
founding.
We assume that there is some additive confounding H in Y , i.e. we assume that (Y, T,X)
has the same distribution under Pconf as (Y + H,T,X) under Punconf. Let P be the set of
distributions Pconf for which the second moment of H is bounded by . For all  > 0, define
sensATE() = max
Pconf∈P
|τ(Punconf)− τ(Pconf)|, and
sensincr() = max
Pconf∈P
|θ(Punconf)− θ(Pconf)|.
In words, sensATE() and sensincr() quantify how robust the identification strategies θ(P) and
τ(P) are under slight violations of the ignorability assumption. The proof of the following result
can be found in the Appendix.
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Theorem 2. For all  > 0 we have
sensincr() =
√
E[−∂2t log p(X,T )],
sensATE() =∞.
As an example, if p(t|x) is Gaussian with variance σ2, then sensincr() =
√

σ . Intuitively, if
there is a lot of variation in T compared to the variation of H, then estimation of the incre-
mental causal effect is relatively little affected. This result shows that estimating the average
treatment effect from observational data using the ignorability assumption is oftentimes less
robust to confounding than estimating the effect of incremental interventions if the ignorability
assumption is slightly violated. Of course, this result is conservative as we are dealing with
worst-case additive confounding in an -ball around the unconfounded distribution Punconf. Ro-
bustness of regression estimators of incremental treatment effects and the average treatment
effect in a simulation setting where the ignorability assumption is violated can be found in
Section 5.3.
4.3 Doubly-robust estimation and confidence intervals under sparsity
In this section we describe a simple procedure to derive asymptotically valid confidence intervals
using the lasso. “Doubly robust” is meant in the sense that the method yields asymptotically
valid confidence intervals if the function class B either contains ∂t log p(t, x) or f0. The method
we describe is based on the method on page 6 in Bu¨hlmann and van de Geer (2015). However,
we will transform the features in a pre-processing step. This transformation will depend on the
observations (ti, xi) and change for every n, which adds some complexity. The benefit of this
pre-processing step is to reduce the problem of estimating incremental treatment effects to a
problem of estimating a single component in a high-dimensional, potentially misspecified linear
model. As a result, existing software such as the R-package hdi (Meier, 2019) can be used to
efficiently estimate incremental treatment effects. Of course, the results below also extend to
the low-dimensional case, i.e. to the case where the number of features p is fixed and the number
of observations n goes to infinity.
As above, consider basis functions b1(t, x), . . . , bp(t, x) of B which are potentially non-linear.
To make notation simpler without loss of generality we assume that b1(t, x) = t. Assume we have
an i.i.d. sample (yi, ti, xi), i = 1, . . . , n, and define the feature matrix X via Xk;i = bk(ti, xi),
the target vector Y = (y1, . . . , yn)
ᵀ and the transformed feature matrix X˜ via
X˜k;i =
{
ti for k = 1,
bk(ti, xi)− ti 1n
∑n
i=1 ∂tbk(ti, xi) for k > 1.
(9)
This can be thought of as an orthogonalization step. Thus, we call this technique “incremental
effect orthogonalization”. By construction, for k > 1 the features (X˜k;i)i=1,...,n are asymptoti-
cally uncorrelated of the Riesz representer of the average partial effect, (−∂t log p(ti, xi))i=1,...,n.
Using implicit or explicit orthogonality properties is common in semiparametric approaches.
For general functionals the orthogonalization step can be more involved, see for example Cher-
nozhukov et al. (2018). The intuition behind the orthogonalization step is as follows: If we
define the transformed functions b˜k = bk(t, x) − tαk with αk = 1n
∑n
i=1 ∂tbk(ti, xi) for k > 1
and b˜k = t for k = 1, then also b˜1, . . . , b˜p is a basis of B. Hence, if f0 ∈ B, we can write it as
f0 =
∑
k β
0
k b˜k. And in particular, we have the average derivative
θfs =
1
n
n∑
i=1
∂tf
0(ti, xi) =
p∑
k=1
β0k
1
n
n∑
i=1
∂tb˜k = β
0
1 . (10)
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The following proposition is a direct result of the observation above.
Proposition 2. Assume that b1, . . . , bp is a basis of the function class B. Assume that Y =
f0(T,X) +  for  independent of (T,X) and that f0 ∈ B. Let (yi, ti, xi, i)i=1,...,n be i.i.d.
with the same distribution as (Y, T,X, ) and denote E the expectation with respect to the i,
i = 1, . . . , n. Then,
θfs = β
0
1 ,
where
β0 ∈ arg min
β
E
[
1
n
n∑
i=1
(yi −
∑
k
b˜k(ti, xi)βk)
2
]
.
Thus, we have transformed the problem of estimation and inference for subpopulation or
sample incremental causal effects θfs to the problem of doing estimation and inference of one
component in a (potentially high-dimensional) linear model. Several approaches have been
developed to do inference in high-dimensional linear models (Meinshausen et al., 2009; Liu and
Yu, 2013; Zhang and Zhang, 2014; Javanmard and Montanari, 2014; Van de Geer et al., 2014;
Belloni et al., 2014). However, using one of these methods with the transformed data (X˜,Y)
does not guarantee that we still have asymptotically valid inference if the Riesz representer
∂t log p(t, x) ∈ B, but f0 6∈ B for f0 := E[Y |X = x, T = t]. In other words, this approach does
not automatically guarantee a double robustness property if the outcome model is misspecified.
In the following we discuss how to obtain double robustness properties for estimating the super
population effect θsp. Compared to existing approaches (Powell et al., 1989; Hirshberg and
Wager, 2019; Chernozhukov et al., 2018), the main difference is that the orthogonalization is
done in a simple pre-processing step which allows us to rely on commonly used Lasso software
for high-dimensional regression models.
Define the two Lasso estimators
γˆ := arg min
γ
‖X1 − X˜−1γ‖22/n+ 2λX‖γ‖1,
βˆ := arg min
β
‖Y − X˜β‖22/n+ 2λ‖β‖1.
Furthermore, define the desparsified estimator for the first component
βˆdespar1 =
Z˜ᵀY
Z˜ᵀX1
−
∑
k>1
Z˜ᵀX˜k
Z˜ᵀX1
βˆk, where
Z˜ = X1 − X˜−1γˆ.
Note that this desparsified estimator is defined analogously as in the regression literature (Zhang
and Zhang, 2014; Javanmard and Montanari, 2014; Van de Geer et al., 2014; Belloni et al., 2014).
To formulate the assumptions and the result, we need some additional notation.
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Notation. Define
X˜0k;i =
{
ti for k = 1,
bk(ti, xi)− tiE[∂tbk(t1, x1)], for k > 1,
γ0 = arg min
γ
E[‖X1 − X˜0−1γ‖22],
β0 = arg min
β
E[‖Y − X˜0β‖22],
Z˜0 = X1 − X˜0−1γ0,
ˆ = Y − X˜βˆ,
 = Y − X˜0β0.
Assumptions. As mentioned before, our work builds on Bu¨hlmann and van de Geer (2015).
In comparison to their work, the main difference in terms of assumptions is that we added
assumption (A8), see below. As in our setting log(p)/n → 0, assumption (A8) means that the
`1-norm of the population regression coefficient β
0 is bounded and that the `1 norm of γ
0 grows
slower than
√
n/ log(p). Thus, we consider the added assumption (A8) as rather weak. Viewed
in total, the assumptions are strong and in particular require that the nonlinear functions bk
and ∂tbk and the error terms are bounded.
(A1) E[(X˜0)ᵀX˜0]/n has smallest eigenvalue lower bounded by C1 > 0.
(A2) We assume that there exists a constant C2 such that P[|bk(ti, xi)| > C2] = 0 and the
P[|∂tbk(ti, xi)| > C2] = 0 for all k.
(A3) ‖Z˜0‖∞ ≤ C3 <∞.
(A4) s1 = |{k : γ0k 6= 0}| = o(
√
n/ log(p))
(A5) s0 = |{k : β0k 6= 0}| = o(
√
n/ log(p))
(A6) The normalized asymptotic error is bounded from below: for
u2 = Var
(
1Z˜
0
1
E[Z˜01X˜011]
+
∑
k
∂tbk(t1, x1)β
0
k
)
,
we have u2 ≥ C4 > 0.
(A7) The error is bounded ‖‖∞ ≤ V .
(A8) ‖β0‖1 is bounded by a constant and ‖γ0‖1 = o(
√
n/ log(p)).
The assumptions (A5) and (A7) can be relaxed. For details, see Bu¨hlmann and van de Geer
(2015). Now let us turn to the result.
Theorem 3. Let (yi, xi, ti), i = 1, . . . , n be i.i.d. and assume that (A1)–(A8) holds. Then,
for λX = D2
√
log(p)/n and λ = D1
√
log(p)/n with constants D1, D2 sufficiently large and√
log(p)/n→ 0, √
n(βˆdespar1 − β01)
uˆ
⇀ N (0, 1), (11)
where uˆ2 is the empirical variance of
ˆiZ˜i
(Z˜)ᵀX˜1/n
+
∑
k
∂tbk(ti, xi)βˆk, for i = 1, . . . , n.
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Note that we neither assumed f0 ∈ B nor ∂t log p(t, x) ∈ B. The variance has two compo-
nents. Loosely speaking, one part of the variance is induced by the randomness in the treatment
assignment T , the other component comes from the randomness in . The following result shows
under which conditions we have β01 = E[∂tE[Y |X,T ]]. The result is a variation of well-known
results for doubly robust estimation of causal parameters, see for example Bang and Robins
(2005). For reasons of completeness, we include a proof in the Appendix.
Lemma 1. If f0 = E[Y |X = x, T = t] ∈ B or ∂t log p(t|x) ∈ B, then β01 = E[∂tE[Y |X,T ]].
This shows that estimation and inference is doubly robust: if one of the two functions f0 or
∂t log p lie in B, we obtain consistency for the average partial effect, i.e. βˆdespar1 → E[∂tE[Y |X,T ]]
with asymptotically valid confidence intervals. If both f0 ∈ B and ∂t log p(t|x) ∈ B then the
proposed estimator reaches the semiparametric efficiency bound,
Var(∂tf
0) + Var()E[(∂t log p(T |X))2].
A proof of this result can be found in the Appendix, Lemma 5.
5 Simulations
In this section, we validate our theoretical results on simulated data, including settings where
the assumptions of our theoretical results are violated and set-ups based on real-world data. In
Section 5.1 we discuss a very simple low-dimensional model, where the features are drawn from
a Gaussian or t-distribution. In the first setting, the assumptions of Theorem 1 are satisfied,
whereas in the second setting the assumptions of Theorem 1 are violated. In Section 5.2, to
increase the realism of our simulation study, the covariates are taken from the enhancer data
set. In Section 5.3 we investigate robustness of incremental treatment effects under the afore-
mentioned low-dimensional model under varying additive confounding. Finally, in Section 5.4
we discuss a setting in which it is challenging to estimate incremental treatment effects. The
results indicate that the conclusions of Theorem 1 are relatively robust under violations of the
assumptions and that estimating incremental effects can be challenging if the error variance is
large at the edge of the observation space.
5.1 Synthetic data set
In this section we compare estimation and statistical inference for the sample incremental causal
effects θfs and the (relative) sample average treatment effect τfs as defined in Section 4.1 in two
simple scenarios. The first setting was chosen such that the assumptions of Theorem 1 are
satisfied, whereas the second setting was chosen such that the assumptions of Theorem 1 are
violated. In both cases, the regression surfaces were chosen such that they exhibit moderate
curvature across the observation space. In the first scenario we generate n i.i.d. observations
according to the following equations:
t ∼ N (0, 1)
 ∼ Unif(0, 1)
y = 3t+ t2 + 
(12)
We fit a cubic model y ∼ t + t2 + t3 using ordinary least squares and then we use the simple
plug-in estimators θˆ to estimate θfs and τˆ to estimate τfs with t =
1
2 , t
′ = −12 as defined in
Section 4.1.
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Table 1: Coverage of confidence intervals, length of confidence intervals and root mean-squared
error for estimating sample incremental treatment effects and sample average treatment effects
using a cubic model. The data is generated according to equation (12).
n=10 n=20 n=50
CI coverage sample incr 0.97 ± 0.01 0.96 ± 0.01 0.95 ± 0.01
CI coverage sample ATE 0.94 ± 0.01 0.94 ± 0.02 0.95 ± 0.01
CI length sample incr 1.01 ± 0.04 0.4 ± 0.01 0.19 ± 0
CI length sample ATE 1.27 ± 0.07 0.57 ± 0.01 0.29 ± 0
RMSE sample incr 0.24 ± 0.02 0.1 ± 0 0.05 ± 0
RMSE sample ATE 0.28 ± 0.03 0.14 ± 0.01 0.07 ± 0
Table 2: Coverage of confidence intervals, length of confidence intervals and root mean-squared
error for estimating sample incremental treatment effects and sample average treatment effects
using a cubic model. The data is generated according to equation (13).
n=10 n=20 n=50
CI coverage sample incr 0.82 ± 0.02 0.72 ± 0.03 0.62 ± 0.03
CI coverage sample ATE 0.9 ± 0.02 0.74 ± 0.03 0.25 ± 0.03
CI length sample incr 0.81 ± 0.03 0.32 ± 0.01 0.17 ± 0
CI length sample ATE 1.08 ± 0.04 0.48 ± 0.01 0.25 ± 0
RMSE sample incr 0.24 ± 0.01 0.14 ± 0.01 0.09 ± 0
RMSE sample ATE 0.27 ± 0.02 0.2 ± 0.01 0.26 ± 0.01
As we are fitting a linear model, asymptotically valid confidence intervals for both the
incremental treatment effect and the average treatment effect can be readily computed using
standard formulae. Coverage, average length of the resulting confidence intervals and root
mean-squared error for varying sample size n are given in Table 1 below. Note that the model
is well-specified, thus we expect asymptotically correct coverage for both estimators for their
specific target quantities. In both cases, coverage is approximately correct. However, note that
the average length of confidence intervals for the effect of the incremental effect is smaller than
the respective length for the average treatment effect. This is expected and in line with our
theory as the assumptions for Theorem 1 hold. Now let us turn to a case where the model is
misspecified. We generate n samples according to the equations below.
t ∼ t4
 ∼ Unif(−1, 1)
y = 3t+ t2 + t3 + |t|+ ,
(13)
where t4 denotes a t-distribution with 4 degrees of freedom. Then, we fit a cubic model y ∼
t + t2 + t3 using ordinary least squares and then use simple plug-in estimators for the sample
incremental effect and the average treatment effect as above. However, in this case, neither
of the confidence intervals are asymptotically valid due to model misspecification. Coverage,
average length of the (asymptotically invalid) confidence intervals and root mean-square error
are given in Table 2.
Notably, while both confidence intervals have asymptotically incorrect coverage, incremental
causal effects have lower root mean-squared error and lower asymptotic variance. Thus, while
the assumptions for Theorem 1 do not hold in this case, estimating incremental effects is still
easier in terms of asymptotic mean squared-error for our choices of estimators. Of course, there
exist also scenarios in which it is harder to estimate incremental than average treatment effects.
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Table 3: Root mean-squared error of estimating the sample average treatment effect and sample
incremental treatment effect. The estimator of incremental causal effects exhibits consistently
lower error variance. The noise is drawn from a centered Gaussian distribution with unit vari-
ance. For the feature vector, a subset of size eight is randomly selected from S ⊂ {1, . . . , 666}.
For each of the k ∈ S ∪ {1}, we draw β0k ∼ exp(λ) with λ =
√
10 and set β0k = 0 otherwise.
n=200 n=400 n=600 n=1000
RMSE sample incr 0.14 ± 0.01 0.12 ± 0.01 0.1 ± 0.01 0.08 ± 0
RMSE sample ATE 0.16 ± 0.01 0.14 ± 0.01 0.13 ± 0.01 0.11 ± 0.01
This is further discussed in Section 5.4.
5.2 Simulations based on an enhancer data set
We aim to investigate estimation of the average derivative using the transformation proposed
in Section 4.3. To increase the realism of our simulation study, we consider features from a
real-world data set. More specificaly, we consider the activity of 36 transcription factors in
Drosophila embryos on n = 7809 segments of the genome (Li et al., 2008; MacArthur et al.,
2009). As the features are heavy-tailed, a square-root transform was performed. The activity
of the transcription factors is obtained using the following approach: A transcription-specific
antibody is used to filter segments of DNA from the embryo. The filtered segments are measured
using microarrays and mapped back to the genome, resulting in a genome-wide map of DNA
binding for each transcription factor. Then, n = 7809 segments of the genome are selected
based on background knowledge about enhancer activity. The main effects and interactions
of transcription factors form a 7809 × 666-dimensional feature matrix X. We consider two
simulation settings which differ in the way the vector β0 is formed. In one case, the non-zero
entries of β0 are constant 1, whereas in the other case the non-zero entries of β0 are sampled
from an exponential distribution:
Exponential β0: As a feature vector, we randomly select a subset of size eight of the main
effects and interactions of the transcription factors, S ⊂ {1, . . . , 666}. For each of the effects
k ∈ S ∪ {1}, we draw β0k ∼ exp(λ) with λ =
√
10 and β0k = 0 otherwise.
Constant β0: For the feature vector we randomly select a subset S ⊂ {1, . . . , 666} of size eight.
For each of the selected k ∈ S ∪ {1}, we set β0k = 1, and set β0k = 0 for k 6∈ S.
We draw n samples i from a standard Gaussian distribution with unit variance. Then, we
form observations
yi = Xi,•β + i.
We report both the mean-squared error for θfs corresponding to the first component for varying
sample size using the method described in Section 4.3. The tuning parameters λ and λX are
chosen via cross-validation. As treatment effect, we consider
τ(t, t′),
where t and t′ are both randomly drawn from the empirical distribution of T . For fairness of
comparison, we also use the desparsified lasso to estimate the sample average treatment effect.
The results can be found in Table 3 and Table 4.
Evidently, in this simulation setting, estimating the average treatment effect results in higher
asymptotic variance as estimating the incremental effect. This is in line with the theory pre-
sented in Section 4.1. This phenomenon seems relatively stable across varying choices of simu-
lation parameters as can be seen in the Appendix.
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Table 4: Root mean-squared error of estimating the sample average treatment effect and sample
incremental treatment effect. The estimator of incremental causal effects exhibits consistently
lower error variance. The noise is drawn from a centered Gaussian distribution with unit vari-
ance. For the feature vector, a subset of size eight is randomly selected from S ⊂ {1, . . . , 666}.
For each of the k ∈ S ∪ {1}, we set β0k = 1 and for k 6∈ S ∪ {1} we set β0k = 0.
n=200 n=400 n=600 n=1000
RMSE sample incr 0.59 ± 0.02 0.45 ± 0.02 0.3 ± 0.01 0.13 ± 0.01
RMSE sample ATE 0.67 ± 0.02 0.63 ± 0.02 0.52 ± 0.02 0.31 ± 0.02
5.3 Robustness to local confounding
In Section 4.2, we discussed that identification of incremental causal effects is often more ro-
bust under worst-case confounding than identification of average treatment effects in regression
settings. In this section, we investigate the behavior of the plug-in estimators τˆ and θˆ under con-
founding. Roughly speaking, we add hidden confounding h so that for subjects with treatment
assignment T ∈ [a, b], the local ignorability assumption does not hold. We call r = P[a ≤ T ≤ b]
the ratio of confounding as it corresponds to the ratio of subjects for which the local ignor-
ability assumption does not hold. We chose the simulation such that the regression surface
exhibits moderate curvature. Specifically, we generate n = 100 i.i.d. observations according to
the following equations:
ξ, ξ′ ∼ N (0, 1/2)
 ∼ Unif(−.5, .5)
t = ξ + ξ′
y = 3t+ t2 + hconf(t)
√
2ξ + ,
where the confounder ξ only acts locally,
hconf(t) =

0 for t < a,
t− a for a ≤ t < b,
b− a for b ≤ t.
A cubic model y ∼ t+t2+t3 is fitted using ordinary least squares. We use the plug-in estimators
θˆ and τˆ as defined in Section 4.1 to estimate θfs and τfs with t =
1
2 , t
′ = −12 . We investigate
two cases. In Figure 3, we choose the endpoints of the interval [a, b] randomly and average the
mean-squared error over all intervals with fixed ratio of confounded subjects r = P[a < X < b].
In Figure 4, we consider the worst-case mean-squared error, where the maximum is taken over
all intervals [a, b] with the same ratio of confounded subjects r. In both cases, the RMSE
increases under confounding and the estimator for the incremental causal effect is more robust
than the estimator for the average treatment effect. Under worst-case additive confounding,
the gap in RMSE between θˆ and τˆ widens. Theoretical underpinnings of this discrepancy in
robustness can be found Section 4.2.
5.4 Challenges of estimating incremental treatment effects
Of course, there exist scenarios where estimating the effect of incremental interventions is con-
siderably harder than estimating average treatment effects. For example, performance can suffer
if the error variance is larger at the tails of T than in the bulk of the observations. In this case,
estimating an average treatment effect τ(t, t′), where t and t′ are in the bulk of the observations,
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Figure 3: Root mean-squared error under confounding. For a ratio r ∈ [0, 1] of the subjects,
the local ignorability assumption is violated. The plug-in estimator θˆ for the incremental treat-
ment effect θfs is more robust under confounding than the plug-in estimator τˆ for the average
treatment effect τfs in this setting.
Table 5: Root mean-squared error under heteroscedasticity. Estimating incremental treatment
effects is difficult as the error variance at the edge of the observation space is large. In this
scenario, estimating the average treatment effect τ(.5,−.5) is relatively easy as both t = .5 and
t′ = −.5 are in regions where the error variance is low.
n=100 n=200 n=500
RMSE sample incr 0.097 ± 0.004 0.067 ± 0.003 0.04 ± 0.002
RMSE sample ATE 0.059 ± 0.003 0.041 ± 0.002 0.026 ± 0.001
is relatively easy compared to estimating incremental causal effects. As an example, we generate
i.i.d. observations according to the following equations:
t ∼ Unif(−.5, 1.5)
 ∼ Unif(−.5, .5)
y = t2 + |t| · 
As before, a cubic model y ∼ t+ t2 + t3 is fitted using ordinary least squares. Then, the plug-in
estimators estimators θˆ and τˆ(.5,−.5) are calculated as in Section 4.1. The root mean-squared
error under varying sample size is reported in Table 5. As expected, for large n the mean-squared
error E[(τˆ − τfs)2] is smaller than the mean-squared error E[(θˆ− θfs)2]. If the error variance for
subjects at the edge of the observation space is very large, we recommend estimating average
and incremental treatment effects for a subgroup that exhibits lower error variance.
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Figure 4: Root mean-squared error under worst-case confounding. For a ratio r ∈ [0, 1] of
the subjects, the local ignorability assumption is violated. The plug-in estimator θˆ for the
incremental treatment effect θfs is more robust under confounding than the plug-in estimator τˆ
for the average treatment effect τfs in this setting. Theoretical underpinnings for the discrepancy
in robustness can be found Section 4.2.
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6 Conclusion
The estimation of treatment effects is of central interest in many disciplines. Often, treatment
effects are estimated under the assumption of weak ignorability and the overlap condition.
Both of these assumptions are strong and easily violated if the data is observational. In this
paper, we have shown that these assumptions can be substantially weakened for identification
of incremental treatment effects. We introduced a local ignorability assumption and a local
overlap condition and show that incremental treatment effects are identifiable under these two
new local conditions. As an example, treatment assignment might be randomized locally within
subgroups of patients but not across all patients.
In simulation studies, we have seen some evidence indicating that the estimation of the
average treatment effect using a plug-in estimator has often higher variance than a comparable
estimator for the incremental treatment effect. If the distribution of the treatment given the
covariates is Gaussian, we have shown that this difference in asymptotic error is indeed system-
atic. Moreover, we have shown that estimation of incremental treatment effects is usually more
robust under worst-case additive confounding than estimation of average treatment effects.
We discussed how to obtain asymptotically valid confidence intervals that are doubly robust
both in terms of estimation and inference using a two-step procedure. In the first step, a
feature transformation is performed. We call this feature transformation ”incremental effect
orthogonalization”. In the second step, an ordinary lasso regression is performed.
Causal inference from observational data is known to be unreliable and has to be done
with extreme care. In high-stake scenarios such as healthcare this can have devastating effects
on human lives. We have identified situations where incremental effects can be more reliably
estimated than average treatment effects. In those settings, estimating incremental effects
might be more informative for practitioners than estimating the average treatment effect. We
hope that our work aids decisions on choice of intervention notions to reliably answer domain
questions.
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8 Appendix
8.1 Additional simulation results
Table 6: Root mean-squared error of estimating the sample average treatment effect and sample
incremental treatment effect. The estimator of incremental causal effects exhibits lower error.
The noise is drawn from a t-distribution with three degrees of freedom. For the feature vector,
a subset of size eight is randomly selected from S ⊂ {1, . . . , 666}. For each of the k ∈ S ∪ {1},
we draw β0k ∼ exp(λ) with λ =
√
10 and set β0k = 0 otherwise.
n=200 n=400 n=600 n=1000
RMSE sample incr 0.23 ± 0.02 0.17 ± 0.01 0.15 ± 0.01 0.13 ± 0.01
RMSE sample ATE 0.24 ± 0.02 0.2 ± 0.02 0.18 ± 0.01 0.16 ± 0.01
Table 7: Root mean-squared error of estimating the sample average treatment effect and
sample incremental causal effect. The estimator of incremental causal effects exhibits lower
error for n > 200. The noise is drawn from a centered t-distribution with 3 degrees of freedom.
For the feature vector, a subset of size eight is randomly selected from S ⊂ {1, . . . , 666}. For
each of the k ∈ S ∪ {1}, we set β0k = 1 and for k 6∈ S ∪ {1} we set β0k = 0.
n=200 n=400 n=600 n=1000
RMSE sample incr 0.73 ± 0.28 0.48 ± 0.02 0.38 ± 0.02 0.21 ± 0.01
RMSE sample ATE 0.68 ± 0.02 0.64 ± 0.02 0.56 ± 0.02 0.38 ± 0.02
8.2 Proof of Proposition 1
Proof. Without loss of generality we will drop “conditional on X”. In the following, choose t
with p(t) > 0. As Y (t) is continuously differentiable with derivative Y ′(t) there exists a random
variable ξδ ∈ [t, t+ δ] such that
Y (t+ δ)− Y (t)
δ
= Y ′(ξδ). (14)
As the derivative Y ′(t) is continuous and bounded, by dominated convergence,
lim
δ→0
E [Y (t+ δ)|T = t]− E[Y (t)|T = t]
δ
= E[Y ′(t)|T = t].
Now choose δ0 > 0 small enough such that both the local overlap condition and local ignorability
is satisfied, i.e. such that p(t′) > 0 for all |t′−t| ≤ δ0 and that Y (t+δ)|T = t d= Y (t+δ)|T = t+δ
for all |δ| ≤ δ0. Hence, for δ close to zero,
E[Y (t+ δ)− Y (t)|T = t] = E[Y (t+ δ)|T = t]− E[Y (t)|T = t]
= E[Y (t+ δ)|T = t+ δ]− E[Y (t)|T = t].
Dividing by δ,
E[Y (t+ δ)− Y (t)|T = t]
δ
=
E[Y (t+ δ)|T = t+ δ]− E[Y (t)|T = t]
δ
.
As shown above, for δ → 0, the limit of the quantity on the left exists and is equal to E[Y ′(t)|T =
t]. Thus, E[Y |T = t] is differentiable and the quantity on the left converges to ∂tE[Y |T =
23
t]. Taking the limit on both sides concludes the proof. In particular, as Y (t) is continously
differentiable with bounded derivative, t 7→ E[Y |T = t] is also continuously differentiable with
bounded derivative in neighborhoods where p(t) > 0.
8.3 Proof of Theorem 1
Proof. Take an orthogonal basis b1, . . . , bp of B, such that b1 = −∂t log p(t|x). For n large
enough, the estimator fˆ can be written as fˆ =
∑
k αˆkbk with unique αˆ1, . . . , αˆp. Define Xj;i =
bj(ti, xi). Note that conditionally on Dfeat, θˆfs and τˆfs are unbiased estimators of θfs and τfs.
Thus, in the following we will derive the conditional asymptotic variance of these estimators.
The conditional variance of the vector αˆ can be written as
(XᵀX)−1E[2]
The conditional variance of αˆ can thus be written as
1
n
·

E[2]
E[b21]
0 . . . 0
0 ∗ . . . ∗
...
...
. . .
...
0 ∗ . . . ∗
+ oP
(
1
n
)
.
Here we used that by choice of b1, . . . , bp we have that E[b1bk] = 0 for all k > 1. In ad-
dition, we used the formula for block-wise inversion and multiplication of matrices. Hence
θˆfs =
1
n
∑n
i=1
∑
k αˆk∂tbk(ti, xi) =
∑
k αˆk
1
n
∑n
i=1 ∂tbk(ti, xi) has asymptotic conditional variance
1
n
· (E[∂tb1] . . . E[∂tbp])

E[2]
E[b21]
0 . . . 0
0 ∗ . . . ∗
...
...
. . .
...
0 ∗ . . . ∗

E[∂tb1]...
E[∂tbp]
+ oP ( 1
n
)
.
Using that by partial integration, E[∂tbk] = E[bkb1] = 0 for all k > 1, θˆfs has asymptotic
conditional variance
1
n
E[∂tb1]2
E[2]
E[b21]
.
We can now use that E[∂tb1]2 = E[b21]2. This gives us asymptotic conditional variance
E[b21]E[2]
n
+ oP
(
1
n
)
.
Through analogous argumentation we obtain that the conditional variance of τˆ is asymptotically
1
n
· (v1 . . . vp)

E[2]
E[b21]
0 . . . 0
0 ∗ . . . ∗
...
...
. . .
...
0 ∗ . . . ∗

v1...
vp
+ oP ( 1
n
)
,
where vk :=
E[bk(t,X)]−E[bk(t′,X)]
t−t′ . Using that the submatrix denoted by “*” is positive semidefi-
nite, the variance of τˆfs is asymptotically lower bounded by
1
n
(
E[b1(t,X)]− E[b1(t′, X)]
t− t′
)2 E[2]
E[b21]
+ oP
(
1
n
)
.
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Recall that we assume that the second derivative of the log-density given X is constant. In this
case, (
E[b1(t,X)]− E[b1(t′, X)]
t− t′
)2
= E[∂1b1]2
Hence, in this case, the variance of τˆfs is asymptotically lower bounded by
E[b21]E[2]
n
+ oP
(
1
n
)
.
Thus, lim infn→∞Var(τˆfs|Dfeat)/Var(θˆfs|Dfeat) ≥ 1.
8.4 Proof of Theorem 2
Proof. We will first prove the result for incremental treatment effects. Set f∗ = −∂t log p(T,X).
Then,
sensincr() = max
E[H2]≤
Econf[f∗Y ]− Eunconf[f∗Y ]
= max
E[H2]≤
Eunconf[f∗(Y +H)]− Eunconf[f∗Y ]
= max
E[H2]≤
Eunconf[f∗H]
=
√

√
E[f2∗ ]
Now, use that E[f2∗ ] = E[∂tf∗] = E[−∂2t log p(t, x)]. In the case of the average treatment effect
use
H =
√

f((T − t)/σ)√
Eunconf[f((T − t)/σ)2]
,
where f is the density function of a standard Gaussian random variable. For σ → 0, Econf[Y |X =
x, T = t]→∞, whereas Econf[Y |X = x, T = t′]→ Eunconf[Y |X = x, T = t′]. This concludes the
proof.
8.5 Proof of Theorem 3 and auxiliary results
The proof follows closely Bu¨hlmann and van de Geer (2015) with some modifications. Before
we proceed, we show that the following auxiliary results hold:
(D1)
max
k
|ᵀX˜k/n| = OP (
√
log(p)/n)
max
k
|ᵀ(X˜k − X˜0k)/n| = OP (
√
log(p)/n)
max
k 6=1
|(X˜ᵀkZ˜0)/n| = OP (
√
log(p)/n)
max
k 6=1
|(X˜k − X˜0k)ᵀZ˜0/n| = OP (
√
log(p)/n)
(D2) ‖γˆ(λX)− γ0‖1 = oP (1/
√
log(p))
(D3) ‖βˆ(λ)− β0‖1 = oP (1/
√
log(p))
25
Lemma 2 (Similar to Lemma 1 in Bu¨hlmann and van de Geer (2015)). Assume (A2), (A3)
and (A7). Then, (D1) holds.
Proof. We will prove the first part of the statement. The other parts of the statement can be
proven analogously. First, note that
E[ max
1≤k≤p
|n−1ᵀX˜k|2] ≤ 2E[ max
1≤k≤p
|n−1ᵀXk|2] + 2E[ max
1≤k≤p
|δk|2], (15)
where δ1 = 0 and δk = n
−1∑
i iti ·n−1
∑
i ∂tbk(ti, xi) for k > 1. Using Nemirowski’s inequality
(Bu¨hlmann and van de Geer, 2011, Lemma 14.24) we obtain:
E[ max
1≤k≤p
|n−1ᵀXk|2] ≤ 8 log(2p)C22V 2/n = O(log(p)/n), (16)
and similarly
E[ max
1≤k≤p
|δk|2] ≤ 8 log(2p)C42V 2/n = O(log(p)/n). (17)
Using equation (16) and equation (17) in equation (15) we obtain
E[ max
1≤k≤p
|n−1ᵀX˜k|2] = O(log(p)/n). (18)
In the next step, we can use Markov’s inequality and E[ᵀX˜k] = 0 to conclude that
P[ max
k=1,...,p
|n−1ᵀX˜k| > c] ≤ E[maxk=1,...,p |n
−1ᵀX˜k|]
c
≤
√
E[maxk=1,...,p |n−1ᵀX˜k|2]
c
= O(
√
log(p)/n).
Lemma 3 (Similar to Lemma 2 in Bu¨hlmann and van de Geer (2015)). Assume (A1) and (A2)
and
√
log(p)/n→ 0.
1. If (A3) and (A4) hold, then for λX = D2
√
log(p)/n with D2 sufficiently large we have
(D2).
2. If (A7) and (A5) holds, then for λ = D1
√
log(p)/n with D1 sufficiently large, we have
(D3).
Proof. The proof proceeds mostly as in Bu¨hlmann and van de Geer (2015). However, there is
one slight complication that the rows of X˜ are not i.i.d. We will prove statement (1). The proof
for statement (2) proceeds analogously.
First, we will prove the compatibility condition for the transformed data X˜. To this end,
note that
1
n
X˜ᵀj X˜k =
1
n
XᵀjXk −
1
n
n∑
i=1
Xi,jXi,1δk − 1
n
n∑
i=1
Xi,1Xi,kδj + δkδj
1
n
n∑
i=1
X2i,1, (19)
where δj =
1
n
∑
i′ ∂tbj(ti′ , xi′) for j > 1 and δj = 0 for j = 1. Using assumption (A2) and
sub-Gaussian tail bounds (Boucheron et al., 2013, Chapter 2), the terms
1
n
XᵀjXk −
1
n
E[XᵀjXk],
δk − E[δk],
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are uniformly of the order OP (
√
log(p)/n). Hence, using equation (19), the term
max
j,k
∣∣∣∣ 1nX˜ᵀj X˜k − 1nE[(X˜0j )ᵀX˜0k]
∣∣∣∣
is of order OP (
√
log(p)/n).
The sparsity assumption (A4) combined with (A1) imply that the compatibility condition
holds with probability converging to one, c.f. Bu¨hlmann and van de Geer (2011, Chapter 6.12).
Using Lemma 2, we obtain ‖X˜ᵀ−1Z˜0‖∞ ≤ OP (
√
n log(p)). Invoking an inequality for the lasso
(Bu¨hlmann and van de Geer, 2011, Chapter 6.1) with assumption (A4), we obtain statement (1).
Proposition 3 (Similar to Proposition 7 in Bu¨hlmann and van de Geer (2015)). Assume (A1),
(A2), (A3), (A6), (A7) and (A8). Write
u2 = Var
(
1Z˜
0
1
E[Z˜01X˜011]
+
∑
k
∂tbk(t1, x1)β
0
k)
)
Then,
√
n
 
ᵀZ˜0/n
E[Z˜01X˜011]
−∑k(E[∂tbkβ0k]− Eˆ[∂tbkβ0k])
u
⇀ N (0, 1). (20)
Proof. By assumption (A6), u is bounded from below. In addition, note that due to (A1),
E[(Z˜0)ᵀX˜01]/n is bounded away from zero and due to (A2) and (A3) it is bounded from above.
Due to (A2) and (A8),
∑
k ∂tbkβ
0
k is bounded. The proof then proceeds analogously to the proof
in Bu¨hlmann and van de Geer (2015) using the Lindeberg condition.
Proposition 4 (Similar to Proposition 8 in Bu¨hlmann and van de Geer (2015)). Assume√
log(p)/n→ 0, (A1), (A2), (A3), (A6), (A7), (A8), (D1), (D2) and (D3). Then:
√
n
 Z˜ᵀZ˜ᵀX˜1 −∑k(E[∂tbkβ0k]− Eˆ[∂tbkβ0k])
u
⇀ N (0, 1) (21)
Proof. We have to show that the difference between equation (20) and equation (21) is of order
oP (1). Note that due to (A6), the quantity u is bounded away from zero and can be ignored.
The difference between equation (20) and equation (21), up to bounded factors, is
√
n
(
Z˜ᵀ
Z˜ᵀX˜1
− 
ᵀZ˜0/n
E[(Z˜01)ᵀX˜011]
)
.
We want to show that this terms goes to zero. Let us assume for a moment that
(1) |ᵀ(Z˜0 − Z˜)/√n| = oP (1),
(2) Z˜ᵀX˜1/n− E[(Z˜01)ᵀX˜011] = oP (1),
(3) ᵀZ˜0/
√
n = OP (1),
(4) E[(Z˜01)ᵀX˜011] is bounded away from zero.
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Then,
√
n
(
Z˜ᵀ
Z˜ᵀX˜1
− 
ᵀZ˜0/n
E[(Z˜01)ᵀX˜011]
)
= ᵀZ˜0/
√
n
(
1
Z˜ᵀX˜1/n
− 1
E[(Z˜01)ᵀX˜011]
)
+ (ᵀZ˜0/
√
n− ᵀZ˜/√n) 1
Z˜ᵀX˜1/n
= oP (1),
which is the desired result. Thus, it remains to show that the claims (1)–(4) hold. Let us first
show claim (1).
|ᵀ(Z˜0 − Z˜)/√n| ≤ |ᵀX˜−1(γˆ − γ0)|/
√
n+ |ᵀ(X˜−1 − X˜0−1)γ0|/
√
n
≤ ‖ᵀX˜−1‖∞‖γˆ − γ0‖1/
√
n+ ‖ᵀ(X˜−1 − X˜0−1)‖∞/
√
n‖γ0‖1
Now we can use (D1), (D2) and (A8) to conclude that this term goes to zero in probability for
n→∞. This proves claim (1). Now let us turn to claim (2). Similarly as proving claim (1) we
can show that
|Z˜ᵀX˜1/n− (Z˜0)ᵀX˜1/n| = | 1
n
X˜ᵀ1X˜−1(γˆ − γ0)|+ |
1
n
X˜ᵀ1(X˜
0
−1 − X˜−1)γ0|
= oP (1).
As X˜1 = X˜
0
1,
|Z˜ᵀX˜1/n− (Z˜0)ᵀX˜01/n| = oP (1). (22)
By (A2) and the law of large numbers,
(Z˜0)ᵀX˜01/n− E[(Z˜01)ᵀX˜011] = oP (1).
Using equation (22) proves claim (2).(
1
Z˜ᵀX˜1/n
− 1
E[(Z˜01)ᵀX˜011]
)
= oP (1).
Due to (A3), (A7) and the definition of , ᵀZ˜0/
√
n = OP (1). This proves claim (3). Claim (4)
follows from assumption (A1).
Proposition 5 (Similar to Proposition 9 in Bu¨hlmann and van de Geer (2015)). Assume (A1),
(A2), (A3), (A6), (A7), (A8), (D1), (D2) and (D3). Then, for λX = D2
√
log(p)/n with D2
sufficiently large and
√
log(p)/n→ 0,
√
n(βˆdespar1 − β01)
u
⇀ N (0, 1),
where u is defined as in Proposition 3.
Proof. Let us recall the definition
βˆdespar1 =
Z˜ᵀY
Z˜ᵀX˜1
−
∑
k 6=1
Z˜ᵀX˜k
Z˜ᵀX˜1
βˆk.
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Then, using that Y = + X˜0β0 = + X˜β0 −∑k 6=1 X˜1(E[∂tbkβ0k]− Eˆ[∂tbkβ0k]),
√
n
Z˜ᵀX˜1
n
(βˆdespar1 − β01)
=
1√
n
Z˜ᵀY −∑
k 6=1
Z˜ᵀX˜kβˆk − Z˜ᵀX˜1β01

=
1√
n
Z˜ᵀ(− X˜1∑
k 6=1
(E[∂tbk]− Eˆ[∂tbk])β0k +
∑
k 6=1
X˜k(β
0
k − βˆk))

=
1√
n
Z˜ᵀ(− X˜1∑
k 6=1
(E[∂tbk]− Eˆ[∂tbk])β0k + X˜−1(β0−1 − βˆ−1))
 .
The latter quantity in this term can be bounded,∣∣∣∣ 1√n Z˜ᵀX˜−1(β0−1 − βˆ−1)
∣∣∣∣
≤ 1√
n
∥∥∥Z˜ᵀX˜−1∥∥∥∞ ∥∥∥(β0−1 − βˆ−1)∥∥∥1
The KKT conditions for the regression of X˜1 on X˜−1 read as
X˜ᵀ−1Z˜/n+ λX κˆ = 0,
for κˆ ∈ [−1, 1]p−1. Thus, ‖X˜ᵀ−1Z˜‖∞ = O(
√
n log(p)). Furthermore, by assumption ‖β0− βˆ‖1 =
oP (1/
√
log(p)). Thus, ∣∣∣∣ 1√n Z˜ᵀX˜−1(β0−1 − βˆ−1)
∣∣∣∣ = oP (1)
Thus,
√
n
Z˜ᵀX˜1
n
(βˆdespar1 − β01)
=
1√
n
Z˜ᵀ(− X˜1∑
k 6=1
(E[∂tbk]− Eˆ[∂tbk])β0k)
+ oP (1).
Rearranging and using property (2) and (4) from the proof of Proposition 4 yields
√
n(βˆdespar1 − β01)
=
√
n
 Z˜ᵀ
Z˜ᵀX˜1
−
∑
k 6=1
(E[∂tbk]− Eˆ[∂tbk])β0k
+ oP (1).
Using Proposition 4 completes the proof.
Proposition 6 (Similar to Proposition 1 in Bu¨hlmann and van de Geer (2015)). Assume√
log(p)/n→ 0, (A1), (A2), (A3), (A6), (A7), (A8), (D2) and (D3). Then,
uˆ2 = u2 + oP (1),
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where uˆ2 is the empirical variance of
ˆiZ˜i
(Z˜)ᵀX˜1/n
−
∑
k
Eˆ[∂tbk]βˆk − ∂tbk(ti, xi)βˆk,
for i = 1, . . . , n and u2 is the variance of
1Z˜
0
1
E[(Z˜01)ᵀX˜01;1]
−
∑
k
E[∂tbkβ0k]− ∂tbk(t1, x1)β0k.
Proof. Define
ξ0i =
iZ˜
0
i
E[(Z˜01)ᵀX˜01;1]
−
∑
k
E[∂tbkβ0k]− ∂tbk(ti, xi)β0k,
and
ξi =
ˆiZ˜i
(Z˜)ᵀX˜1/n
−
∑
k
Eˆ[∂tbk]βˆk − ∂tbk(ti, xi)βˆk.
By assumption (A1), E[(Z˜01)ᵀX˜01;1] is bounded away from zero. Thus, by (A2), (A3), (A7) and
(A8), the ξ0i are bounded. Using the law of large numbers,
1
n
∑
i
ξ0i = E[ξ01 ] + oP (1),
1
n
∑
i
(ξ0i )
2 = E[(ξ01)2] + oP (1).
Thus, it suffices to show that
1
n
∑
i
ξ0i − ξi = oP (1),
1
n
∑
i
(ξ0i )
2 − ξ2i = oP (1).
Note that we have ∣∣∣∣∣ 1n∑
i
ξ0i − ξi
∣∣∣∣∣ | ≤ maxi ∣∣ξ0i − ξi∣∣∣∣∣∣∣ 1n∑
i
(ξ0i )
2 − ξ2i
∣∣∣∣∣ ≤ maxi |ξ0i − ξi|(maxi |ξ0i − ξi|+ maxi |ξ0i |)
(23)
As the ξ0i are bounded, using equation (23) it suffices to show that
max
i
|ξi − ξ0i | = oP (1). (24)
We will do this in two steps.
max
i
|ξi − ξ0i |
≤ max
i
∣∣∣∣∣ iZ˜0iE[(Z˜01)ᵀX˜01;1] − ˆiZ˜i(Z˜)ᵀX˜1/n
∣∣∣∣∣
+ max
i
∣∣∣∣∣∑
k
E[∂tbkβ0k]− ∂tbk(ti, xi)β0k −
∑
k
Eˆ[∂tbk]βˆk − ∂tbk(ti, xi)βˆk
∣∣∣∣∣ .
(25)
30
By assumption, ξ0i and ξi are bounded. Note that
max
i
∣∣∣∣∣∑
k
∂tbk(ti, xi)(β
0
k − βˆk)
∣∣∣∣∣ ≤ maxi maxk |bk(ti, xi)|2‖β0 − βˆ‖1.
Due to assumption (A2), the bk are bounded. Recall that due to (D3), ‖βˆ−β0‖1 = oP (
√
1/ log p).
Thus,
max
i
∣∣∣∣∣∑
k
∂tbk(ti, xi)(β
0
k − βˆk)
∣∣∣∣∣ = oP (1). (26)
Using (A2) and that ‖β0‖1 is bounded, using a sub-Gaussian tail inequality (Boucheron et al.,
2013, Chapter 2), ∣∣∣∣∣∑
k
E[∂tbk]β0k −
∑
k
1
n
∑
i
∂tbk(ti, xi)β
0
k
∣∣∣∣∣ = OP (√log(p)/n). (27)
Combining equation (26) and equation (27), as
√
log(p)/n→ 0,∣∣∣∣∣∑
k
E[∂tbkβ0k]− ∂tbk(ti, xi)β0k −
∑
k
Eˆ[∂tbk]βˆk − ∂tbk(ti, xi)βˆk
∣∣∣∣∣ = oP (1).
Using equation (25), it remains to show that
max
i
∣∣∣∣∣ iZ˜0iE[Z˜01X˜01;1] − ˆiZ˜i(Z˜)ᵀX˜1/n|
∣∣∣∣∣ = oP (1)
Expanding the terms,∣∣∣∣∣ iZ˜0iE[Z˜01X˜01;1] − ˆiZ˜i(Z˜)ᵀX˜1/n
∣∣∣∣∣
≤
∣∣∣∣∣iZ˜0i − ˆiZ˜iE[Z˜01X˜01;1]
∣∣∣∣∣+
∣∣∣∣∣ˆiZ˜i
(
1
(Z˜)ᵀX˜1/n
− 1
E[Z˜01X˜01;1]
)∣∣∣∣∣
≤
∣∣∣∣∣iZ˜0i − ˆiZ˜iE[Z˜01X˜01;1]
∣∣∣∣∣+
∣∣∣∣∣(ˆiZ˜i − iZ˜0i)
(
1
(Z˜)ᵀX˜1/n
− 1
E[Z˜01X˜01;1]
)∣∣∣∣∣
+
∣∣∣∣∣iZ˜0i
(
1
(Z˜)ᵀX˜1/n
− 1
E[Z˜01X˜01;1]
)∣∣∣∣∣ .
(28)
We have shown in Proposition 4 that
Z˜ᵀX˜1/n = E[Z˜01X˜011] + oP (1),
and that the latter quantity is bounded away from zero. Furthermore, by assumption maxi |iZ˜0i |
is bounded. Using equation (28) it suffices to show that
max
i
|iZ˜0i − ˆiZ˜i| = oP (1).
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To this end note that
max
i
|iZ˜0i − ˆiZ˜i|
≤ max
i
|i(Z˜0i − Z˜i)|+ max
i
|(i − ˆi)(Z˜i − Z˜0i )|+ max
i
|(i − ˆi)Z˜0i )|
Now use the following inequalities
‖Z˜0‖∞ ≤ C3 <∞
‖Z˜− Z˜0‖∞ = ‖X˜−1γˆ − X˜0−1γ0‖∞
≤ ‖X˜−1(γˆ − γ0)‖∞ + ‖(X˜−1 − X˜0−1)γ0‖∞
≤ ‖X˜−1‖∞‖γˆ − γ0‖1 + ‖X˜−1 − X˜0−1‖∞‖γ0‖1
= oP (1)
‖ˆ− ‖∞ ≤ ‖X˜(βˆ − β0)‖∞ + ‖(X˜− X˜0)β0‖∞
≤ ‖X˜‖∞‖βˆ − β0‖1 + ‖X˜− X˜0‖∞‖β0‖1
= oP (1)
Here we used that by a sub-Gaussian tail bound (Boucheron et al., 2013, Chapter 2), (A2)
implies ‖X˜ − X˜0‖∞ = OP (
√
log(p)/n). Furthermore, we used that by (A2), ‖X˜‖∞ = OP (1),
that by (D3) we have ‖βˆ−β0‖1 = OP (1/
√
log(p)), by (D2) we have ‖γˆ−γ0‖1 = OP (1/
√
log(p))
and by assumption ‖β0‖1 = O(1) and ‖γ0‖1 = o(
√
n/ log(p)). Hence, we have shown that
1
n
∑
i
ξ0i − ξi = oP (1),
1
n
∑
i
(ξ0i )
2 − ξ2i = oP (1).
As argued above, this concludes the proof.
8.5.1 Proof of Theorem 3
Proof. Combine Lemma 2 and Lemma 3 with Proposition 5 and Proposition 6. Note that due
to assumption (A6), u is bounded away from zero. Thus,
uˆ2
u2
= 1 + oP (1),
which completes the proof.
8.6 Proof of Lemma 1
Proof. Define b˜k = bk − tE[∂tbk] for k > 1 and b˜1 = t. By definition of β0,
β0 = arg min
β
E[‖Y − X˜0β‖22] = arg min
β
E[(Y −
∑
k
b˜k(T,X)β)
2].
Now use Lemma 4. This implies that
E[∂tE[Y |X = x, T = t]] = E[
∑
k
∂tb˜kβ
0
k].
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Expanding the definition,
E[∂tE[Y |X = x, T = t]] =
∑
k
(E[∂tbk]− 1k>1∂ttE[∂tbk])β0k
=
∑
k
(E[∂tbk]− 1k>1E[∂tbk])β0k
= β01 .
This concludes the proof.
8.7 Proof of Lemma 4
Lemma 4. Define
b0 = arg min
b∈B
E[(f0(T,X)− b(T,X))2],
and
b∗ = arg min
b∈B
E[(f∗(T,X)− b(T,X))2],
where f∗ = −∂t log p(t|x). If, P-a.s. we have
b0(T,X) = f0(T,X) or b∗(T,X) = f∗(T,X),
then E[∂tf0] = E[∂tb0].
Proof. As P-a.s. we have b0 = f0 or b∗ = f∗, we also have that P-a.s. (b0 − f0)(b∗ − f∗) = 0.
Hence,
0 =E[(b0 − f0)(b∗ − f∗)]
=E[f0f∗] + E[b0b∗]− E[b0f∗]− E[f0b∗]
=E[f0f∗] + E[b0b∗]− E[b0b∗]− E[b0b∗]
=E[f0f∗]− E[b0b∗]
=E[f0f∗]− E[b0f∗]
Here, we used repeatedly that E[f0b∗] = E[b0b∗] and that E[b0f∗] = E[b0b∗]. Now, using that
0 = E[f0f∗]− E[b0f∗] = E[∂tf0]− E[∂tb0],
completes the proof.
8.8 Proof of Lemma 5
Lemma 5 (Semiparametric efficiency bound). Let the assumptions of Theorem 3 hold. If
f0 ∈ B and ∂t log p(t|x) ∈ B, then the asymptotic variance of
√
n(βˆdespar1 − β01) is equal to
Var(∂tf
0) + Var()E[(∂t log p(T |X))2], which is the semiparametric efficiency bound (Stoker,
1991; Powell et al., 1989).
Proof. First, by Proposition 6, the asymptotic variance of
√
n(βˆdespar1 − β01) is
Var(1)Var(Z˜
0
1)
Var(Z˜01)
2
+ Var(∂tf
0)
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Thus, it suffices to show that
Var(Z0i ) = 1/E[(∂t log p)2] for i = 1, . . . , n.
Write f∗ = −∂t log p. Let us first consider a univariate regression of T on f∗ − tE[∂tf∗]. Then,
the residual variance is
min
α
E[(T + α(f∗ − TE[∂tf∗]))2] = min
α
E[(T (1− αE[∂tf∗]) + αf∗)2]
Expanding, and using that E[Tf∗] = 1,
E[(T (1− αE[∂tf∗]) + αf∗)2]
= E[T 2](1− 2αE[∂tf∗] + α2E[∂tf∗]2)
+ 2α(1− αE[∂tf∗]) + α2E[f2∗ ].
Now we can use that E[f2∗ ] = E[∂tf∗]. Taking the derivative with respect to α, we obtain
−2E[T 2]E[f2∗ ] + 2αE[T 2]E[f2∗ ]2 + 2− 4αE[f2∗ ] + 2αE[f2∗ ]
Setting this term to zero and rearranging
−2E[T 2]E[f2∗ ] + 2 = 2αE[f2∗ ]− 2αE[T 2]E[f2∗ ]2
= αE[f2∗ ](2− 2E[f2∗ ]E[T 2])
Thus, the solution is α = 1/E[f2∗ ] and the resulting residual variance is
min
α
E[(T + α(f∗ − TE[∂tf∗]))2] = E[(f∗/E[f2∗ ])2] = 1/E[f2∗ ]
By definition, f∗ is uncorrelated with b˜k for all k > 1. Thus,
min
α1,...,αp
E[(T −
∑
k>1
αk b˜k)
2] = 1/E[f2∗ ].
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